600062.SS
600062.SS
CNE000000Q94
CHINA RESOURCES DOUBLE-CRANE PH
Loading chart...

Company Profile

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Related stocks

600750.SS
600750.SS • China
CHINA RESOURCES JIANGZHONG PHAR
22.88 CNY
2.18B USD 1Y +3.8%
1513.HK
1513.HK • China
LIVZON PHARMA
22.16 HKD
2.51B USD 1Y -35.7%
600664.SS
600664.SS • China
HARBIN PHARMACEUTICAL GROUP CO
7.39 CNY
2.78B USD 1Y +105.3%
6887.HK
6887.HK • China
SUNSHINE PHARMA
40.06 HKD
2.93B USD 1Y -16.6%
002773.SZ
002773.SZ • China
KHPG
20.66 CNY
2.85B USD 1Y -43.6%
600380.SS
600380.SS • China
JOINCARE PHARMACEUTICAL GROUP I
10.13 CNY
2.77B USD 1Y -19.3%
600867.SS
600867.SS • China
TONGHUA DONGBAO MEDICINES CO LT
7.88 CNY
2.31B USD 1Y -7%
603456.SS
603456.SS • China
ZHEJIANG JIUZHOU PHARMACEUTICAL
16.31 CNY
2.14B USD 1Y -20.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.9% p.a.
Max Drawdown (5Y)
-57.0%
Sharpe Ratio (5Y)
0.10
Beta Factor
-0.07
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -57.0% in the extended horizon.
ende